Immunotherapy and cellular therapies for cancers in kidney transplant patients

Keyphrases

• Immunosuppression 100%
• Cell Therapy 100%
• Kidney Transplant Recipients 100%
• Kidney Transplant 100%
• Immunotherapy Therapy 100%
• Infection Risk 50%
• Clinical Trials 50%
• Novel Therapeutics 50%
• Patient Care 50%
• Cancer Risk 50%
• Long-term Survival 50%
• Cancer Treatment 50%
• Oncologists 50%
• Leading Causes of Death 50%
• Treatment Choice 50%
• Immune Checkpoint Inhibitors 50%
• Nephrologists 50%
• Quality of Life Improvement 50%
• Transplant Recipients 50%
• End-stage Kidney Disease 50%
• Bispecific T-cell Engager (BiTE) 50%
• Immunosuppression Management 50%
• Care Partner 50%
• Chimeric Antigen Receptor T-cell Therapy 50%

Medicine and Dentistry

• Cancer 100%
• Immunotherapy 100%
• Kidney Graft 100%
• Cell Therapy 100%
• Immunosuppressive Treatment 75%
• Malignant Neoplasm 50%
• Cancer Therapy 25%
• Infection 25%
• Clinical Trial 25%
• Patient Care 25%
• Decision Making 25%
• End Stage Renal Disease 25%
• T Cell 25%
• Cancer Treatment 25%
• Quality of Life 25%
• Oncologist 25%
• Immune Checkpoint Inhibitor 25%
• Nephrologist 25%
• Chimeric Antigen Receptor T-Cell Immunotherapy 25%